IRIS UniCatt

Scaldaferri, Franco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.770
AS - Asia 9.375
EU - Europa 8.244
SA - Sud America 2.034
AF - Africa 265
OC - Oceania 46
Continente sconosciuto - Info sul continente non disponibili 20
Totale 30.754
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.377
SG - Singapore 4.250
CN - Cina 2.091
DE - Germania 1.795
BR - Brasile 1.629
IT - Italia 1.587
SE - Svezia 1.372
VN - Vietnam 880
FR - Francia 865
GB - Regno Unito 425
PL - Polonia 368
IE - Irlanda 358
UA - Ucraina 354
IN - India 341
FI - Finlandia 338
ID - Indonesia 284
JP - Giappone 269
HK - Hong Kong 234
CA - Canada 204
TR - Turchia 185
RU - Federazione Russa 179
AR - Argentina 149
MX - Messico 128
KR - Corea 123
BD - Bangladesh 120
NL - Olanda 116
IR - Iran 111
IQ - Iraq 103
ES - Italia 99
ZA - Sudafrica 86
EC - Ecuador 64
BE - Belgio 63
AT - Austria 58
PK - Pakistan 43
CO - Colombia 40
VE - Venezuela 39
SA - Arabia Saudita 38
CZ - Repubblica Ceca 37
UZ - Uzbekistan 37
AU - Australia 36
MA - Marocco 32
PE - Perù 32
CL - Cile 31
PH - Filippine 30
EG - Egitto 29
LT - Lituania 27
CH - Svizzera 26
CI - Costa d'Avorio 26
JO - Giordania 25
TN - Tunisia 25
RO - Romania 22
IL - Israele 20
BG - Bulgaria 19
NP - Nepal 19
PY - Paraguay 18
AZ - Azerbaigian 17
TW - Taiwan 17
EU - Europa 16
PT - Portogallo 16
UY - Uruguay 16
TH - Thailandia 15
AE - Emirati Arabi Uniti 14
MY - Malesia 14
KE - Kenya 13
KZ - Kazakistan 13
AL - Albania 12
HR - Croazia 12
JM - Giamaica 12
DZ - Algeria 11
HU - Ungheria 11
OM - Oman 11
BO - Bolivia 10
BY - Bielorussia 9
CR - Costa Rica 8
ET - Etiopia 8
GR - Grecia 8
SI - Slovenia 8
CY - Cipro 7
DK - Danimarca 7
DO - Repubblica Dominicana 7
HN - Honduras 7
NG - Nigeria 7
NO - Norvegia 7
NZ - Nuova Zelanda 7
PS - Palestinian Territory 7
KG - Kirghizistan 6
LB - Libano 6
RS - Serbia 6
TT - Trinidad e Tobago 6
BA - Bosnia-Erzegovina 5
EE - Estonia 5
KW - Kuwait 5
MK - Macedonia 5
NI - Nicaragua 5
PA - Panama 5
SK - Slovacchia (Repubblica Slovacca) 5
SY - Repubblica araba siriana 5
AM - Armenia 4
GH - Ghana 4
GY - Guiana 4
Totale 30.659
Salva come PNG Salva come JPEG
Città #
Singapore 2.449
Chandler 1.389
Ashburn 1.113
San Jose 1.074
Beijing 462
Dublin 348
Los Angeles 334
New York 328
Rome 315
Warsaw 305
Ho Chi Minh City 286
Lauterbourg 241
Jakarta 239
Jacksonville 238
Tokyo 238
Hefei 233
Hanoi 229
Frankfurt am Main 204
San Mateo 202
The Dalles 187
Munich 186
Hong Kong 185
Milan 181
São Paulo 176
Ann Arbor 170
Boston 169
Dallas 163
Wilmington 157
Nanjing 143
Council Bluffs 140
Helsinki 135
Cattolica 123
Marseille 116
Princeton 114
Houston 110
Fairfield 102
Chicago 98
Seoul 95
Seattle 93
Dearborn 88
Moscow 88
Woodbridge 88
Redwood City 85
London 76
Nürnberg 71
Turku 71
Izmir 70
Orem 70
North Bergen 69
Santa Clara 69
Kent 67
Boardman 66
Nuremberg 66
Montreal 65
Stockholm 65
Brooklyn 64
Hangzhou 63
Lawrence 62
Paris 62
Buffalo 60
Bremen 58
Denver 55
Shanghai 53
Brussels 52
Lappeenranta 52
Baghdad 49
Rio de Janeiro 49
Pune 48
Atlanta 47
Chennai 46
Nanchang 46
Toronto 45
Belo Horizonte 44
Poplar 44
Da Nang 43
Johannesburg 43
Tianjin 42
Phoenix 41
Redmond 41
Amsterdam 40
St Louis 40
Hyderabad 37
Düsseldorf 36
Guangzhou 36
Shenyang 36
Augusta 35
Hebei 35
Lancaster 34
Haiphong 33
Mountain View 33
Cambridge 32
Detroit 32
San Francisco 32
Vienna 32
Mexico City 31
Changsha 29
Zhengzhou 29
Curitiba 28
Kunming 28
Mumbai 28
Totale 16.149
Salva come PNG Salva come JPEG
Nome #
The interpaly between immune system and microbiota in gynecological diseases : a narrative review. 713
Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility 369
Food Components and Dietary Habits: Keys for a Healthy Gut Microbiota Composition. 340
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 306
International consensus conference on stool banking for faecal microbiota transplantation in clinical practice 263
Gut Microbiota Modulation and Mucosal Immunity: Focus on Rifaximin 229
Nutrition and IBD: Malnutrition and/or Sarcopenia? A Practical Guide 229
The role of diet on gut microbiota composition 213
Complex Muco-cutaneous Manifestations of CARMIL2-associated Combined Immunodeficiency: A Novel Presentation of Dysfunctional Epithelial Barriers 213
Role and mechanisms of action of Escherichia coli nissle 1917 in the maintenance of remission in ulcerative colitis patients: an update 208
The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease 207
Management of acute dyarrhea: current and future trends 205
Anti-TNF-α-induced psoriasiform lesions in IBD: an abnormal immune activation or a 'patchy cutaneous' immune suppression? 204
Propionyl-L-carnitine hydrochloride for treatment of mild to moderate colonic inflammatory bowel diseases 202
The gut barrier: new acquisitions and therapeutic approaches 197
Gut Microbiota in Health, Diverticular Disease, Irritable Bowel Syndrome, and Inflammatory Bowel Diseases: Time for Microbial Marker of Gastrointestinal Disorders? 196
Assessment of neurological manifestations in hospitalized patients with COVID-19 193
Vascular involvement in inflammatory bowel disease: pathogenesis and clinical aspects. 188
13C-octanoic acid breath test to study gastric emptying time 181
Bacterial flora as a cause or treatment of chronic diarrhea 179
Efficacy and Mechanisms of Action of Fecal Microbiota Transplantation in Ulcerative Colitis: Pitfalls and Promises From a First Meta-Analysis 179
Gelatin tannate ameliorates acute colitis in mice by reinforcing mucus layer and modulating gut microbiota composition: Emerging role for 'gut barrier protectors' in IBD? 173
Skeletal muscle-gut axis: Emerging mechanisms of sarcopenia for intestinal and extra intestinal diseases 172
Validation of an LC-MS/MS Method for Urinary Lactulose and Mannitol Quantification: Results in Patients with Irritable Bowel Syndrome 171
Intercellular adhesion molecule 1 gene polymorphisms in inflammatory bowel disease 170
Comparison between clinical and radiological evaluation before and after medical therapy in patients with Crohn's disease: new prospective roles of CT enterography 168
RECURRENT PREGNANCY LOSS IS ASSSOCIATED TO LEAKY GUT: A NOVEL PATHOGENIC MODEL OF ENDOMETRIUM INFLAMMATION ? 168
Comparison between clinical and radiological evaluation before and after medical therapy in patients with Crohn's disease: new prospective roles of CT enterography 167
Anti-TNF-related leukocytoclastic vasculitis in ulcerative colitis: a case report 167
Dysbiosis, gut microbiota modulation and intestinal permeability in recurrent cystitis patients and concomitant gastrointestinal pathologies 163
Locally injected Infliximab ameliorates murine DSS colitis: differences in serum and intestinal levels of drug between healthy and colitic mice 162
Use and indications of cholestyramine and bile acid sequestrants 159
Dietary magnesium: the magic mineral that protects from colon cancer? 158
Proinflammatory and Cancer-Promoting Pathobiont Fusobacterium nucleatum Directly Targets Colorectal Cancer Stem Cells 157
The therapeutic management of gut barrier leaking: the emerging role for mucosal barrier protectors 157
Tumour necrosis factor-related apoptosis-inducing ligand (trail): a possible pathogenic role in chronic plaque psoriasis 157
Adverse Food Reactions in Inflammatory Bowel Disease: State of the Art and Future Perspectives 155
The gastrointestinal microbiome - functional interference between stomach and intestine 155
European consensus conference on faecal microbiota transplantation in clinical practice 155
Dietary Magnesium Alleviates Experimental Murine Colitis Through Upregulation of the Transient Receptor Potential Melastatin 6 Channel 155
Comparison of performances of infliximab biosimilars CT-P13 versus SB2 in the treatment of inflammatory bowel diseases: a real-life multicenter, observational study in Italy 155
Solute Transporter OCTN1/Slc22a4 Affects Disease Severity and Response to Infliximab in Experimental Colitis: Role of Gut Microbiota and Immune Modulation 152
Origin of celiac disease: How old are predisposing haplotypes? 152
The Role of Antibiotics in Gut Microbiota Modulation: The Eubiotic Effects of Rifaximin 152
Locally injected Infliximab ameliorates murine DSS colitis: differences in serum and intestinal levels of drug between healthy and colitic mice 151
Tumor necrosis factor-α and solute carrier family 22 member 4 gene polymorphisms as potential determinants of intestinal dysbiosis 151
-Extraintestinal manifestations in inflammatory Bowel disease. 150
Tricks for interpreting and making a good report on hydrogen and 13C breath tests 148
Body mass index influences infliximab post-infusion levels and correlates with prospective loss of response to the drug in a cohort of inflammatory bowel disease patients under maintenance therapy with Infliximab 148
Use of Faecal Transplantation with a Novel Diet for Mild to Moderate Active Ulcerative Colitis: The CRAFT UC Randomised Controlled Trial 147
Intestinal Permeability and Dysbiosis in Female Patients with Recurrent Cystitis: A Pilot Study 146
Prevention and treatment of venous thromboembolism in patients with IBD: a trail still climbing. 145
Differential CD133 expression pattern during mouse colon tumorigenesis 144
Rifaximin for the treatment of diarrhoea-predominant irritable bowel syndrome 143
Herbal medicinal products for inflammatory bowel disease: A focus on those assessed in double-blind randomised controlled trials 143
The role of inflammatory bowel disease nurses for patients on biologic therapy during the COVID-19 pandemic 143
Switching from VEDOlizumab intravenous to subcutaneous formulation in ulcerative colitis patients in clinical remission: The SVEDO Study, an IG-IBD study 142
Intestinal gas production and gastrointestinal symptoms: from pathogenesis to clinical implication 141
Sustainability of Endovenous Iron Deficiency Anaemia Treatment: Hospital-Based Health Technology Assessment in IBD Patients 141
Gut microbial flora, prebiotics and probiotics in IBD: their current usage and utility 139
Bacillus clausii and gut homeostasis: state of the art and future perspectives 139
Fecal microbiota transplantation for recurrent Clostridioides difficile infection in patients with concurrent ulcerative colitis 138
Microbes and Alzheimer' disease: Lessons from H. Pylori and GUT microbiota 138
Mucosal biomarkers in inflammatory bowel disease: key pathogenic players or disease predictors? 137
A novel pathogenic role for microvasculature in inflammatory bowel disease. 136
Combination therapy in inflammatory bowel disease – from traditional immunosuppressors towards the new paradigm of dual targeted therapy 136
Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review 135
Transition from intravenous to subcutaneous biological therapies in inflammatory bowel disease: An online survey of patients 135
Signs of dissociation and symptoms of post-traumatic stress disorder in inflammatory bowel disease. A case-control study 134
Case report: Dupilumab treatment improved type 2 disorders in a patient with IPEX syndrome diagnosis 133
Pre- and posttherapy assessment of intestinal soluble mediators in IBD: where we stand and future perspectives 132
Acute refractory intestinal pseudo-obstruction in MELAS: efficacy of prucalopride 132
International consensus statement on microbiome testing in clinical practice 131
Haemostatic system in inflammatory bowel diseases: new players in gut inflammation. 131
Cost-effectiveness analysis of genetic diagnostic strategies for Lynch syndrome in Italy 131
Dietary magnesium alleviates experimental murine colitis through modulation of gut microbiota 130
Pre- and posttherapy assessment of intestinal soluble mediators in IBD: where we stand and future perspectives 129
Specific 13C functional pathways as diagnostic targets in gastroenterology breath-tests: tricks for a correct interpretation 129
Use and indications of cholestyramine and bile acid sequestrants 128
Drug-Related Pneumonitis in Patients Receiving Vedolizumab Therapy for Inflammatory Bowel Disease 128
Akkermansia muciniphila: key player in metabolic and gastrointestinal disorders 126
Impact of COVID-19 pandemic on the daily management of biotechnological therapy in inflammatory bowel disease patients: Reorganisational response in a high-volume Italian inflammatory bowel disease centre 126
Commensal Clostridia: leading players in the maintenance of gut homeostasis 125
Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility 125
Microparticles produced by activated platelets carry a potent and functionally active angiogenic signal in subjects with crohn’s disease 125
Switching from IFX originator to biosimilar CT-P13 does not impact effectiveness,safety and immunogenicity in a large cohort of IBD patients 125
Prevention and treatment of venous thromboembolism in patients with IBD: a trail still climbing 124
Mesenchymal Stem Cells Reduce Colitis in Mice via Release of TSG6, Independently of Their Localization to the Intestine 124
The current practice of lynch syndrome diagnosis and management in Italy: A qualitative assessment 124
Gut Microbiota Modulation in IBD: From the Old Paradigm to Revolutionary Tools 122
A) Platelets: new players in the mucosal scenario of inflammatory bowel disease. 122
Direct effect of infliximab on intestinal mucosa sustains mucosal healing: Exploring new mechanisms of action 122
Characterization of Sarcopenia in an IBD Population Attending an Italian Gastroenterology Tertiary Center 121
Cancer and Mediterranean Diet: A Review 121
Multiparametric Evaluation Predicts Different Mid-Term Outcomes in Crohn's Disease 121
Knowledge of Diagnostic and Therapeutic Aspects of IBD Among Nurses Working in Digestive Endoscopy: A Nationwide Italian Survey 121
An Integrative Multi-omic Analysis defines Gut Microbiota, Mycobiota and Metabolic fingerprints in Ulcerative Colitis Patients 120
Fibrostenosing Crohn's Disease: Pathogenetic Mechanisms and New Therapeutic Horizons 120
Pancreatic function assessment 120
Correction to: Recurrent pregnancy loss is associated to leaky gut: a novel pathogenic model of endometrium inflammation? 120
Totale 16.352
Salva come PNG Salva come JPEG
Categoria #
all - tutte 123.548
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 123.548
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021305 0 0 0 0 0 0 0 0 0 74 199 32
2021/20221.736 120 83 37 101 122 56 26 240 86 190 343 332
2022/20233.919 507 507 296 597 235 466 192 328 453 80 160 98
2023/20242.392 103 536 98 153 99 315 186 94 127 135 263 283
2024/20255.247 103 152 429 154 431 199 313 206 634 587 1.112 927
2025/202613.083 1.915 526 936 1.860 2.452 736 2.203 734 999 722 0 0
Totale 31.203